These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 27481315

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.
    Tiberi S, Sotgiu G, D'Ambrosio L, Centis R, Abdo Arbex M, Alarcon Arrascue E, Alffenaar JW, Caminero JA, Gaga M, Gualano G, Skrahina A, Solovic I, Sulis G, Tadolini M, Alarcon Guizado V, De Lorenzo S, Roby Arias AJ, Scardigli A, Akkerman OW, Aleksa A, Artsukevich J, Auchynka V, Bonini EH, Chong Marín FA, Collahuazo López L, de Vries G, Dore S, Kunst H, Matteelli A, Moschos C, Palmieri F, Papavasileiou A, Payen MC, Piana A, Spanevello A, Vargas Vasquez D, Viggiani P, White V, Zumla A, Migliori GB.
    Eur Respir J; 2016 Jun; 47(6):1758-66. PubMed ID: 27076583
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Linezolid: an effective, safe and cheap drug for patients failing multidrug-resistant tuberculosis treatment in India.
    Singla R, Caminero JA, Jaiswal A, Singla N, Gupta S, Bali RK, Behera D.
    Eur Respir J; 2012 Apr; 39(4):956-62. PubMed ID: 21965225
    [Abstract] [Full Text] [Related]

  • 7. Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis.
    Sotgiu G, Centis R, D'Ambrosio L, Alffenaar JW, Anger HA, Caminero JA, Castiglia P, De Lorenzo S, Ferrara G, Koh WJ, Schecter GF, Shim TS, Singla R, Skrahina A, Spanevello A, Udwadia ZF, Villar M, Zampogna E, Zellweger JP, Zumla A, Migliori GB.
    Eur Respir J; 2012 Dec; 40(6):1430-42. PubMed ID: 22496332
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients.
    Koh WJ, Kang YR, Jeon K, Kwon OJ, Lyu J, Kim WS, Shim TS.
    J Antimicrob Chemother; 2012 Jun; 67(6):1503-7. PubMed ID: 22403262
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical outcomes of linezolid treatment for extensively drug-resistant tuberculosis in Beijing, China: a hospital-based retrospective study.
    Liu Y, Bao P, Wang D, Li Y, Tang L, Zhou Y, Zhao W.
    Jpn J Infect Dis; 2015 Jun; 68(3):244-7. PubMed ID: 25672406
    [Abstract] [Full Text] [Related]

  • 15. First series of patients with XDR and pre-XDR TB treated with regimens that included meropenen-clavulanate in Argentina.
    Palmero D, González Montaner P, Cufré M, García A, Vescovo M, Poggi S.
    Arch Bronconeumol; 2015 Oct; 51(10):e49-52. PubMed ID: 26026689
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of linezolid in the treatment of extensively drug-resistant tuberculosis.
    Tangg SJ, Zhang Q, Zheng LH, Sun H, Gu J, Hao XH, Liu YD, Yao L, Xiao HP.
    Jpn J Infect Dis; 2011 Oct; 64(6):509-12. PubMed ID: 22116331
    [Abstract] [Full Text] [Related]

  • 17. A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis.
    Migliori GB, Eker B, Richardson MD, Sotgiu G, Zellweger JP, Skrahina A, Ortmann J, Girardi E, Hoffmann H, Besozzi G, Bevilacqua N, Kirsten D, Centis R, Lange C, TBNET Study Group.
    Eur Respir J; 2009 Aug; 34(2):387-93. PubMed ID: 19282348
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen.
    Ndjeka N, Schnippel K, Master I, Meintjes G, Maartens G, Romero R, Padanilam X, Enwerem M, Chotoo S, Singh N, Hughes J, Variava E, Ferreira H, Te Riele J, Ismail N, Mohr E, Bantubani N, Conradie F.
    Eur Respir J; 2018 Dec; 52(6):. PubMed ID: 30361246
    [Abstract] [Full Text] [Related]

  • 20. Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.
    Rose PC, Hallbauer UM, Seddon JA, Hesseling AC, Schaaf HS.
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1588-93. PubMed ID: 23032215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.